| Feature | Specification |
|---|---|
| Application | Cell Signaling |
| Sample Volume | 15 µL |
Loading...
Please note control lysates are NOT included in the kits. Control lysates are sold separately, catalog number TRF4000S.
Formats:
LANCE® and LANCE® (Lanthanide chelate excite) Ultra are homogeneous (no wash) TR-FRET (time-resolved fluorescence resonance energy transfer) technologies. One antibody of interest is labeled with a donor fluorophore (a LANCE Europium chelate) and the second antibody is labeled with an acceptor fluorophore [ULight™ dye]. Upon excitation at 320 or 340 nm, energy can be transferred from the donor Europium chelate to the acceptor fluorophore if sufficiently close for FRET (~10 nm). This results in the emission of light at 665 nm. Data are represented as ratiometric (665/615 nm X 10,000).
ERK1 and ERK2, also known as MAP Kinase 3 and MAP Kinase 1, are serine/threonine kinases and important targets for cancer treatment. ERK kinases are dually phosphorylated at Tyr-202 and Tyr-204, leading to activation of the target. ERK can also be dephosphorylated at Tyr-202 by PTPRJ. A number of downstream targets have been identified including EIF4EBP1, which is necessary for the initiation of translation. It has also been shown to phosphorylate ELK-1.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
LANCE Ultra
|
| Cellular or Signaling Pathway |
MAPK
|
| Detection Modality |
LANCE
|
| Molecular Modification |
Phosphorylation
|
| Product Group |
Kit
|
| Sample Volume |
15 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
ERK1/2
|
| Target Class |
Phosphoproteins
|
| Technology |
TR-FRET
|
| Therapeutic Area |
Cardiovascular
Metabolic
Neuroscience
|
| Unit Size |
500 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
Emerging pathways to neuroinflammation and neurodegeneration
Neurodegenerative diseases, such as amyotrophic lateral sclerosis...
LANCE™ Ultra TR-FRET is a no-wash proximity assay technology that combines the benefits of time resolution (TR) with fluorescence...
STAT3 is a particularly important therapeutic target since it is constitutively active in a range of cancer cells lines and human...
We are here to answer your questions.